News
Super investors like Buffett and Michael Bury piled heavily into UnitedHealthcare in Q2, signalling confidence that the ...
1d
TipRanks on MSNCVS Health Issues $4 Billion in Senior Notes
CVS Health ( ($CVS) ) has shared an announcement. On August 11, 2025, CVS Health Corporation entered into an Underwriting ...
3d
TipRanks on MSNCVS vs. UNH: Which Healthcare Stock is a Better Buy After Q2 Earnings?
CVS Health ($CVS) and UnitedHealth Group ($UNH), two of the largest players in the healthcare sector, recently reported their ...
CVS Health has agreed to sell and issue about $4 billion in notes. The healthcare giant entered into an underwriting agreement with Barclays, J.P. Morgan Securities and Wells Fargo Securities on Aug.
StockStory.org on MSN4d
CVS Q2 Deep Dive: Pharmacy Strength and Aetna Recovery Drive Guidance Boost
Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.4% ...
It’s time for a wellness check at CVS Health. Shares of the company are down more than 20% this year as it grapples with higher-than-expected medical costs in its insurance unit and pharmacy ...
This effort, announced at a “Make Health Tech Great Again” event at the White House, is focused on laying the foundation for ...
CVS beat Wall Street estimates in its second quarter earnings Thursday, bringing relief to a stock under pressure from higher costs.
13d
Zacks.com on MSNZacks Investment Ideas feature highlights: CVS Health, Johnson & Johnson and Tenet Healthcare
CVS, JNJ, and Tenet Healthcare shine as defensive picks with strong earnings momentum and attractive valuations.
Through the power of strategic, well-built partnerships, CVS Health helps employees earn degrees — and at no cost to them.
In a press release, CVS highlighted that by combining its health services and Oak Street Health, the company will have a "premier value-based care enterprise" as Oak Street employs more than 600 ...
CVS Health CVS 0.0% (NYSE: CVS) reported its Q3 results earlier this month, with revenues and earnings beating the street estimates, and we believe that CVS stock is undervalued, as discussed below.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results